CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker

BACKGROUND: CLK2 is a splicing regulator and expressed ubiquitously in various malignancies. The study is aimed at exploring the potential roles of CLK2 in the development of colorectal cancer (CRC). METHODS: Real-time PCR and analyses of The Cancer Genome Atlas (TCGA) and Human Protein Atlas (HPA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jiarui, Lin, Guixing, Chen, Binbin, Yuan, Jinpeng, Zhuang, Yezhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289758/
https://www.ncbi.nlm.nih.gov/pubmed/35860803
http://dx.doi.org/10.1155/2022/7250127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289758/
https://www.ncbi.nlm.nih.gov/pubmed/35860803
http://dx.doi.org/10.1155/2022/7250127

Ejemplares similares